Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IXAZOMIB vs IXEKIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IXAZOMIB vs IXEKIZUMAB: Safety Overview

Metric IXAZOMIB IXEKIZUMAB
Total FAERS Reports 22,324 33,680
Deaths Reported 4,704 470
Death Rate 21.1% 1.4%
Hospitalizations 7,433 2,424
Average Patient Age 70.3 yrs 52.0 yrs
% Female Patients 47.2% 60.2%
FDA Approval Date Nov 20, 2015 N/A
Manufacturer Takeda Pharmaceuticals America, Inc. Eli Lilly and Company
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription